Recurrent Myxoid Liposarcoma

  • Rajesh GuptaEmail author


Myxoid liposarcoma is the second most common subtype of liposarcoma and accounts for 10% of all soft tissue sarcomas. PET in combination with MRI is excellent at differentiating recurrent tumor from edema, inflammation, and scarring in the patient that has undergone surgery and radiation therapy. Follow-up PET/MR imaging can provide information on changes in tumor size, metabolism, and tumor necrosis and determine response to therapy with decreasing metabolic activity being favorable.


Myxoid liposarcoma Liposarcoma Lipoma Soft tissue sarcoma FDG PET/MR 

Suggested Reading

  1. Buchbender C, Heusner TA, Lauenstein TC, Bockisch A, Antoch G. Oncologic PET/MRI, part 2: bone tumors, soft-tissue tumors, melanoma, and lymphoma. J Nucl Med. 2012;53:1244–52.CrossRefPubMedGoogle Scholar
  2. Murphey MD, Arcara LK, Fanburg-Smith J. From the archives of the AFIP: imaging of musculoskeletal liposarcoma with radiologic-pathologic correlation. Radiographics. 2005;25:1371–95.CrossRefPubMedGoogle Scholar
  3. Partovi S, Kohan AA, Zipp L, Faulhaber P, Kosmas C, Ros PR, et al. Hybrid PET/MR imaging in two sarcoma patients – clinical benefits and implications for future trials. Int J Clin Exp Med. 2014;7:640–8.PubMedPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing AG 2018

Authors and Affiliations

  1. 1.Department of RadiologyStony Brook University HospitalStony BrookUSA

Personalised recommendations